Contract Service Providers Gear Up to Develop Emerging Therapies

June 15, 2016

Volume 2016 ebook, Issue 1

Page Number: 10–17

Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.

Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies. 

The panelists in this roundtable discussion included: John Allinson, head of biomarker strategy, drug development services at LGC; Martha S. Rook, head of novel therapies, process solutions, MilliporeSigma; Joe Codamo, general manager, Patheon; Brian Hampson, Vice-President, Global Manufacturing Sciences and Technology, PCT, a Caladrius Company; Stephen Gacheru, Executive Director–Biopharmaceutical Product Development, PPD Laboratories; Bruce Stauffer, Executive Director–Immunochemistry Department, PPD Laboratories; and Mark Rogers, VP USA–Life Science, SGS.

Download the

.